🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07015359
Starting soon Observational

Renal Functions in Preeclamptic Pregnant Women Using Neutrophil Gelatinase-associated Lipocalin (NGAL) and Standard Renal Function Tests

NCT07015359 · tracked via the Priya Life Science Turkey tracker
Sponsor
Nihan Aydin Guzey
Phase
Observational
Started
2025-06-08
Last updated
2025-06-11

Condition(s) studied

AnesthesiaSpinal AneshtesiaAcute Kidney FailureSpinal Anesthesia Induced HypotensionPreeclampsia (PE)

Study summary

Acute kidney injury (AKI) is a significant postoperative complication. Risk factors for AKI include impaired renal perfusion, decreased functional renal reserve, as well as advanced age, peripheral arterial disease, diabetes mellitus, renovascular disease and congestive heart failure. Mean arterial pressure (MAP) below 55-60 mmHg has been associated with postoperative AKI. Traditional diagnostic criteria for AKI include increased serum creatinine levels and oliguria. However, creatinine levels do not rise until more than half of renal function is lost. Serum and urine NGAL levels rise earlier-within 24-48 hours-making it a promising early biomarker.

In our study, hypotension is defined as systolic blood pressure \<100 mmHg or a \>30% decrease in MAP. Patients requiring ephedrine under these conditions will be evaluated as the hypotension group and compared with non-hypotensive patients in terms of NGAL, BUN (blood urea nitrogen), creatinine, and GFR (Glomerular Filtration Rate) values at baseline and at the 4th postoperative hour.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Patients classified as ASA physical status II-III * Pregnant women aged 18-45 years, diagnosed with preeclampsia and scheduled for elective cesarean section, will be included in the study. Exclusion Criteria: * Patients who are unable to read, understand, or sign the informed consent form * Patients with a diagnosed renal disease * Patients who do not wish to participate in the study * Patients with ASA physical status greater than III * Patients younger than 18 or older than 45 years * Patients requiring sedation or undergoing general anesthesia * Patients with cardiac instability * Patients with known arrhythmias

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara City Hospital Ankara Ankara

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07015359 on ClinicalTrials.gov ↗ ← All trials in Turkey